THE INTEGRITY OF THE PEER REVIEW SYSTEM AS USED AT THE NATIONAL INSTITUTES OF HEALTH I. Background From a level of approximately $35 million provided for the National Institutes of Health (NIH) in fiscal year 1950, the Federal investment for biomedical research in that agency has grown to over $2.5 billion in fiscal year 1977. With re only minor perturbations overall growth has been steady, oe reflecting confidence in biomedical research for improvements f in the health of our citizens and reaffirming the primary role 5 of the Federal government in the support of advancing knowledge. From the time that the Federal role was established, support for research training has also been an explicit recognition that the long term vigor of the enterprise is dependent on a constant infusion of well-trained investigators. The consequence has been the creation of the world's foremost biomedical research endeavor as a unique partnership between the public sector and the biomedical science community. To carry out the responsibility for the large-scale investment of tax-derived funds, the NIH developed a system for the allocation of its research funds. A key factor in the concept adopted was that prominent scientists active at the cutting edge of science in the laboratory or clinical setting were in the best position to assess the scientific merit of proposals submitted for Federal funding and to recommend those potentially most contributory to the objective of improving health through increasing new knowledge. As the size of the research program expanded, the scientific members of the legislatively mandated National Advisory Councils soon were unable to cope with the research components of the grant applications, given the diversity and number of proposals submitted. To meet the new demands the NIH created by administrative action a two tier review system that, with refinements, is still in use. This arrangement consists of: 1) discipline or specialty oriented initial review groups (IRG's), comprised of recognized experts in those areas and charged with assessing the scientific quality of each grant application, and 2) legislatively mandated National Advisory Councils, including both scientific and lay personnel, which had been assigned the task of recommending those proposals deemed most worthy of the investment of Federal funds. This system has been repeatedly examined by a variety of prestigious groups and has invariably been acclaimed as serving the public interest extraordinarily well in allocating Federal funds for research. In fact other research supporting organizations in both the public and private sectors have emulated the NIH concept and system. Most recently the Congress has seen fit to explicitly mandate review by a peer system for various types of research programs. It should be noted that the overall grant application review system at NIH also represents one of the best bargains currently available to the Federal government. Present estimates place the cost of that system at about one dollar for every $100 requested. Were the NIH forced to reimburse the individuals constituting these panels for the total time expended in the preparation for application review and at the rate they are able to command as consultants or to expand its own staff to encompass the review responsibility, the cost would be enormously greater. Despite minor criticisms -- which for the most part have been successfully refuted -- the system has withstood the test of time. It is not surprising, therefore, that threats to it, arising either externally or internally, are viewed within the scientific community and elsewhere with the gravest concern. II. The Problem Several recent developments together with longstanding governing principles have converged to cause a strikingly serious overloading of the NIH grants review system that constitutes in the opinion of long-time, well-informed observers, the most ominous threat to its integrity that the system has faced since its inception. The elements, cited below, contri- buting to this situation are several: ®